DRUG TRANSPORT IN THE BRAIN - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 443

78. Potschka H, Fedrowitz M, Loscher W. 2003. Multidrug resistance protein MRP2
contributes to blood-brain barrier function and restricts antiepileptic drug activity. J
Pharmacol Exp Ther 306:124-131.
79. Schuetz JD, Connelly MC, Sun D, Paibir SG, Flynn PM, Srinivas RV, Kumar A, Fridland
A. 1999. MRP4: a previously unidentified factor in resistance to nucleoside-based
antiviral drugs. Nat Med 5:1048-1051.
80. Jedlitschky G, Burchell B, Keppler D. 2000. The multidrug resistance protein 5 functions
as an ATP-dependent export pump for cyclic nucleotides. J Biol Chem 275:30069-30074.
81. Chen ZS, Lee K, Kruh GD. 2001. Transport of cyclic nucleotides and estradiol 17-beta-
D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and
6-thioguanine. J Biol Chem 276:33747-33754.
82. Dallas S, Schlichter L, Bendayan R. 2004. Multidrug resistance protein (MRP) 4-
and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia. J
Pharmacol Exp Ther 309:1221-1229.
83. Dallas S, Miller DS, Bendayan R. 2006. Multidrug resistance-associated proteins:
expression and function in the central nervous system. Pharmacol Rev 58:140-161.
84. Zhang Y, Han H, Elmquist WF, Miller DW. 2000. Expression of various multidrug
resistance-associated protein (MRP) homologues in brain microvessel endothelial cells.
Brain Res 876:148-153.
85. Nies AT, Jedlitschky G, Konig J, Herold-Mende C, Steiner HH, Schmitt HP, Keppler
D. 2004. Expression and immunolocalization of the multidrug resistance proteins,
MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 129:349-360.
86. Miller DS, Nobmann SN, Gutmann H, Toeroek M, Drewe J, Fricker G. 2000. Xenobiotic
transport across isolated brain microvessels studied by confocal microscopy. Mol
Pharmacol 58:1357-1367.
87. Berezowski V, Landry C, Dehouck MP, Cecchelli R, Fenart L. 2004. Contribution of glial
cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-
associated proteins in an in vitro model of the blood-brain barrier. Brain Res 1018:
1-9.
88. Leggas M, Adachi M, Scheffer GL, Sun D, Wielinga P, Du G, Mercer KE, Zhuang Y,
Panetta JC, Johnston B, et al. 2004. Mrp4 confers resistance to topotecan and protects
the brain from chemotherapy. Mol Cell Biol 24:7612-7621.
89. Zhang Y, Schuetz JD, Elmquist WF, Miller DW. 2004. Plasma membrane localization of
multidrug resistance-associated protein homologs in brain capillary endothelial cells. J
Pharmacol Exp Ther 311:449-455.
90. Kusch-Poddar M, Drewe J, Fux I, Gutmann H. 2005. Evaluation of the immortalized
human brain capillary endothelial cell line BB19 as a human cell culture model for the
blood-brain barrier. Brain Res 1064:21-31.
91. Dallas S, Miller DS, Bendayan R. 2006. Multidrug resistance-associated Proteins (MRPs):
Expression and function in the central nervous system. Pharmacol Rev 58:140-161.
92. Choudhuri S, Cherrington NJ, Li N, Klaassen CD. 2003. Constitutive expression of
various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. Drug
Metab Dispos 31:1337-1345.
93. Soontornmalai A, Vlaming ML, Fritschy JM. 2006. Differential, strain-specific cellular
and subcellular distribution of multidrug transporters in murine choroid plexus and
blood-brain barrier. Neuroscience 138:159-169.